Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Patent
1995-06-05
1998-11-10
Scheiner, Toni R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
4241381, 4241431, 4241541, 4241561, 4241781, 4241811, 4241831, 5303877, 5303871, 53038822, 53038875, 5303888, 53038885, 5303896, 5303897, C07K 1628, C07K 1646, A61K 39395
Patent
active
058339833
ABSTRACT:
The present invention is related to the field of receptor molecules and complexes. More particularly, the present invention is related to a new polypeptide receptor for interleukin-2 having a molecular weight of about 70-75,000, which is a component of the high affinity IL-2 receptor, antibodies against this new polypeptide, and recombinant interleukins capable of binding to the new receptor. Various applications of the p70-75 receptor, the anti-p70-75 antibodies and IL-2W.sub.1 and IL2W.sub.2 have also been described.
REFERENCES:
patent: 5352772 (1994-10-01), Smith
Tsudo et al., Proc. Natl. Acad. Sci. USA 83:9694-9698, 1986.
Waldmann, Science 232:727-732, 1986.
Waldmann, Cellular Immunology 99:53-60, 1986.
Greene et al. Annals of Internal Medicine 105:560-572, 1986.
Waldmann, et al. Haematology and Blood Transfusion 31:110-115, 1987.
Siegel, et al. Science 238:75-78, 1987.
Waldmann, Environmental Health Perspectives 75:11-15, 1987.
Tsudo, et al. Proc. Natl. Acad. Sci USA 84:5394-5398, 1987.
Tsudo et al., Proc. Natl. Acad. Sci. USQ 84:4215-4218, 1987.
Robb et al. Journal of Experimental Medicine 165:1201-1206, 1987.
Robb et al. Proc. Natl. Acad. Sci. USA 84:2002-2006, 1987.
Teshigaware et al. J. Exp. Med. 165:223-238, 1987.
Wornmann, Bernhard et al. "Structure/Function Analyses of IL-2 Binding proteins on Human B Cell Percursor Acute Lymphoblastics Leukemias", Chemical Abstracts, vol. 108, 1988, p. 456.
Kozak et l. Proc. Natl. Acad. Sci. USA 83:474,478, 1986.
Kronke et al. Cancer Research 46:3295-3298, 1986.
Sugie et al. "The Signal Transduction at Interleukin-2(IL-2) Receptor: On the Roles of Two Types of IL-2 Receptors", Sch. Med., 1987: CA107(25):23458m.
Sharon et al. "Novel Interleukin-2 Receptor Subunit Detected by Cross-Linking Under High-Affinity Conditions", Reports, Nov. 14, 1986, pp. 859-863.
Herrmann et al. "The Mouse High Affinity IL 2 Receptor Complex", Immunobiology, 175(3), 1987, 145-58.
Osawa et al. "Partial Characterization of the Putative Rat Interleukin 2 Receptor", Eur. J. Immunol. 1984, 14:374:376.
Dukovich et al. "A Second Human Interleukin-2 Binding Protein That May be a Component of High-Affinity Interleukin-2 Receptors", Nature, Vol. 327, 11 Jun. 1987, pp. 518-522.
Robb et al. "Internalization of Interleukin 2 is Mediated by the B Chain of the High-Affinity Interleukin 2 Receptor", J. Exp. Med., 1987, 165:1201-1206.
Tsudo et al. "Demonstration of a Non-Tac Peptidinding Protein That May be a Component of High-Affinity Interleukin-2 Receptors", Nature, vol. 327, 11 Jun. 1987, pp. 518-522.
Kozak, R.W. et al. 1986. PNAS USA 83:474-478.
Kronke, M. et al. 1986. Cancer Res. 46:3295-3298.
Leonard Warren J.
Waldmann Thomas A.
Johnson Nancy A.
Scheiner Toni R.
The United States of America as represented by the Secretary of
LandOfFree
Interleukin 2 receptor and applications thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interleukin 2 receptor and applications thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin 2 receptor and applications thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1514035